Arcadia Biosciences, Inc.
RKDA· Nasdaq
Who holds Arcadia Biosciences, Inc., from the managers’ Form 13F reports for the quarter ended Sep 30, 2026.
Form 13F covers managers with $100 million or more. Positions are as of the quarter end and filed up to 45 days later; the latest quarter fills in as reports land.
| Manager | Shares | Change | Value | Of portfolio | Filed |
|---|---|---|---|---|---|
| Armistice Capital, LLC | 476.4K | New | $133.4K | 0.1% | Nov 16, 2026 |
| Two Sigma Securities, LLC | 30.9K | New | $8.7K | 0.1% | Nov 16, 2026 |
| Jump Financial, LLC | 24.3K | New | $6.8K | 0% | Nov 13, 2026 |
| Citadel Advisors LLC | 22.9K | −3.6% | $6.4K | 0% | Nov 16, 2026 |
| Geode Capital Management, LLC | 16.1K | ±0% | $4.5K | 0% | Nov 6, 2026 |
| State Street Corp | 12.1K | ±0% | $3.4K | 0% | Nov 12, 2026 |
| Vanguard Capital Management LLC | 9.6K | ±0% | $2.7K | 0% | Nov 13, 2026 |
| Bullock Wealth Management Group | 1K | ±0% | $284 | 0.1% | Oct 9, 2026 |
| SBI Securities Co., Ltd. | 120 | ±0% | $34 | 0% | Oct 22, 2026 |
| TD Waterhouse Canada Inc. | 70 | ±0% | $19 | 0% | Oct 16, 2026 |
| UBS Group AG | 44 | +25.7% | $13 | 0% | Nov 10, 2026 |
| HRT Financial LP | 26.1K | −70.5% | $7 | 0% | Nov 13, 2026 |
| Group One Trading LLC | 18 | ±0% | $5 | 0% | Nov 10, 2026 |
| Pinnacle Financial Group, Inc. | 8 | — | $2 | 0% | Nov 16, 2026 |
| Morgan Stanley | 2 | ±0% | $1 | 0% | Nov 13, 2026 |
| Southern Michigan Bank & Trust | 2 | ±0% | $1 | 0% | Oct 19, 2026 |
| Barclays PLC | 1 | New | $0 | 0% | Nov 6, 2026 |
| Caitong International Asset Management Co., Ltd | 1 | ±0% | $0 | 0% | Oct 29, 2026 |
| Harbour Investments, Inc. | 1 | ±0% | $0 | 0% | Nov 9, 2026 |